Representative appearances

• Riding Global Tailwinds with EQT's Jean Eric Salata | At the Money

  A medical aesthetics company that provided a major liquidity event for EQT.

• Riding Global Tailwinds with EQT's Jean Eric Salata | Masters in Business

  A medical aesthetics company that was a major successful exit for EQT.

• Schnabel 'Comfortable' with ECB rate Hike Bets, Traders Await Fed Decision | The Opening Trade 12/8

  Dermatological company producing Botox and fillers.

• Unilever Down, Galderma Rises, Monte Paschi Up | Stock Movers

  Secondly, skins care in the spotlight with Galerma. I I read that this morning. I can't say I know that name. Uh what's the story there? Um so L'Oreal has doubled its stake in Galerma this morning. So Galerma is a company that is uh in skincare but is known primarily for making injectables. So Botox, fillers, etc., but then just in the kind of wider dermatology space. Um so now the stake from L'Oreal is now 20%. So that is uh doubled from the 10% that L'Oreal took last year. So it's really reinforcing that investment in dermatology and trying to gain maybe a stronger foothold as well in that injectables market. Um analysts have said that the investment makes a lot of strategic sense. Uh you've got one company that has got that leadership in dermatology and then the other kind of brings that expertise as a leading beauty company. Of course L'Oreal being such a big name. Um, Galama shares were up on the back of that, but L'Oreal shares are actually down. So, it might be because L'Oreal has been making so many deals recently. It recently bought a South Korean brand called Dr. G. It took a majority stake in a UK skincare brand called Medicaid. Um, so perhaps one too many deal for investors this morning, but for Galama it was definitely seen as a positive.